PBYI
HEALTHCAREPuma Biotechnology Inc
$7.45+0.10 (+1.36%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PBYI Today?
No stock-specific AI insight has been generated for PBYI yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.85$7.90
$7.45
Fundamentals
Market Cap$379M
P/E Ratio12.2
EPS$0.61
Dividend Yield—
Dividend / Share—
ROE0.3%
Profit Margin0.1%
Debt / Equity—
Trading
Volume485K
Avg Volume (10D)—
Shares Outstanding50.9M
PBYI News
21 articles- Earnings call transcript: Puma Biotech Q1 2026 misses EPS, revenue forecastsInvesting.com Canada·May 8, 2026
- Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 7, 2026
- Puma Biotechnology Reports First Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·May 6, 2026
- Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial ResultsYahoo Finance·Apr 23, 2026
- Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?Yahoo Finance·Apr 8, 2026
- US Market's Hidden Gems: 3 Undiscovered Small Caps with Strong PotentialYahoo Finance·Apr 7, 2026
- Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?Yahoo Finance·Apr 1, 2026
- As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?Motley Fool·Mar 23, 2026
- Puma Biotechnology Stock Declines More Than 9% in a Month: Here's WhyYahoo Finance·Mar 18, 2026
- IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?Yahoo Finance·Mar 12, 2026
- PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 ViewYahoo Finance·Feb 27, 2026
- Puma Biotechnology, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 27, 2026
- Puma Biotechnology Q4 Earnings Call HighlightsMarketbeat·Feb 27, 2026
- Puma Biotechnology Inc (PBYI) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...Yahoo Finance·Feb 27, 2026
- Puma Biotech (PBYI) Q4 Earnings and Revenues Beat EstimatesYahoo Finance·Feb 26, 2026
- Puma Biotech (PBYI) Earnings Call TranscriptMotley Fool·Feb 26, 2026
- Puma Biotech: Q4 Earnings SnapshotYahoo Finance·Feb 26, 2026
- Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Feb 26, 2026
- Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue EstimatesYahoo Finance·Feb 25, 2026
- Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care ConferenceYahoo Finance·Feb 23, 2026
All 21 articles loaded
Price Data
Open$7.44
Previous Close$7.35
Day High$7.70
Day Low$7.40
52 Week High$7.90
52 Week Low$2.85
52-Week Range
$2.85$7.90
$7.45
Fundamentals
Market Cap$379M
P/E Ratio12.2
EPS$0.61
Dividend Yield—
Dividend / Share—
ROE0.3%
Profit Margin0.1%
Debt / Equity—
Trading
Volume485K
Avg Volume (10D)—
Shares Outstanding50.9M
About Puma Biotechnology Inc
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and internationally. The company is headquartered in Los Angeles, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—